- Cytokines BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand) and their role in autoimmune diseases2008 | First Faculty of Medicine
- Increased serum levels of B-cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.2009 | First Faculty of Medicine
- Increased serum BAFF Levels in Patients with myositis and anti-Jo-1 antibodiesPublication without faculty affiliation
- B cell activating factor (BAFF) in serum and evaluation of disease activity in systemic lupus erythematosus2015 | Faculty of Medicine in Hradec Králové
- Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopatic inflamatory myopathies.Publication without faculty affiliation
- Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies2014 | First Faculty of Medicine
- Increase of intracellular BAFF in B cells of Sjögren's patients is not affected by decrease of BAFFR2015 | Faculty of Medicine in Hradec Králové
- Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney Allograft2016 | Central Library of Charles University
- Alteration of B cell subsets and the receptor for B cell activating factor (BAFF) in paediatric patients with type 1 diabetes2017 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C)2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis2018 | First Faculty of Medicine
- Biological therapy of systemic lupus erythematodus - focused on belimubab2014 | First Faculty of Medicine
- Increased Serum BAFF Levels in Patients with Inflammatory MyopathiesPublication without faculty affiliation
- Serum BAFF Levels in Patients with myositis and anti-Jo-1 antibodiesPublication without faculty affiliation
- Biological therapy in systemic lupus erythematosus2014 | First Faculty of Medicine
- The two mRNA transcription variants of the B-cell activating factor are differentially expressed, but in a stable ratio2014 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients2016 | First Faculty of Medicine, Second Faculty of Medicine
- Low marginal zone-like B lymphocytes and natural antibodies characterize skewed B-lymphocyte subpopulations in del22q11 DiGeorge patients2015 | Second Faculty of Medicine
- Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis2017 | First Faculty of Medicine
- The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy2011 | First Faculty of Medicine
- Multiple sclerosis and immune system biomarkers: Novel comparison in glatiramer acetate and interferon beta-1a-treated patient groups2021 | Faculty of Medicine in Hradec Králové
- Identification and validation of biomarkers associated with acute and chronic graft versus host disease2015 | Third Faculty of Medicine
- An immunotherapy effect analysis in Rasmussen encephalitis2020 | First Faculty of Medicine, Second Faculty of Medicine
- Emerging role of monoclonal antibodies in the treatment of IgA nephropathy2023 | First Faculty of Medicine
- The Arctic : an overview of the most important international expeditions and discoveries2024 | Publication without faculty affiliation
- Changes in innate and adaptive immunity over the first year after the onset of type 1 diabetes2020 | Second Faculty of Medicine, Faculty of Mathematics and Physics
- Cytokine networking of innate immunity cells: a potential target of therapy2014 | First Faculty of Medicine